Equities

STERIS plc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

STERIS plc

Actions
Health CareMedical Equipment and Services
  • Price (USD)237.55
  • Today's Change-0.70 / -0.29%
  • Shares traded242.38k
  • 1 Year change+9.28%
  • Beta0.9271
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.

  • Revenue in USD (TTM)5.46bn
  • Net income in USD610.12m
  • Incorporated2016
  • Employees17.79k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Solventum Corp8.31bn379.00m13.58bn22.00k36.084.1614.711.632.182.1847.6918.850.56834.267.74377,636.402.59--3.05--54.71--4.55--0.85231.930.7081--0.6954---64.41------
Align Technology Inc3.98bn409.56m14.27bn20.95k35.823.7925.443.585.495.4953.4151.940.64954.553.96190,061.706.6813.909.9420.5069.9271.2410.2920.951.08--0.000.003.5410.69-5.32-0.9865-5.04--
Hologic Inc4.03bn556.70m14.44bn7.06k27.353.1316.913.592.372.3717.3120.730.46662.576.24570,083.606.4513.127.2715.2056.4460.8213.8324.752.52110.530.3540.00-0.00253.6673.14--4.30--
Cooper Companies Inc3.99bn414.20m14.62bn16.00k35.541.7618.803.672.062.0619.8641.540.32611.585.43249,262.503.398.723.689.7367.2065.7010.3926.351.236.800.23780.2828.417.9833.34-3.177.59--
Baxter International Inc10.77bn-277.00m15.91bn38.00k--2.2522.571.48-0.5388-1.1021.0313.800.43882.645.04283,447.40-1.09-0.8441-1.37-1.0336.7338.63-2.49-2.031.403.650.5882--2.66-1.31-293.68---8.524.12
Illumina Inc4.34bn-965.00m15.96bn8.97k--6.77--3.68-6.10-6.1027.2314.890.53472.606.36483,500.60-11.90-10.33-14.50-12.1566.3465.65-22.25-25.301.4817.300.4566---2.934.29-5.34---9.34--
West Pharmaceutical Services Inc2.90bn467.20m15.97bn10.60k34.925.9526.045.516.376.3739.4737.370.80214.635.30273,188.7012.5615.6115.0018.7034.5438.0015.6618.842.03--0.071610.20-1.929.48-16.9715.3124.435.84
Zimmer Biomet Holdings Inc7.70bn913.40m18.53bn17.00k20.761.509.622.414.514.5138.0662.630.35290.96225.17452,852.904.192.344.752.6871.0571.1811.887.601.466.460.366537.523.85-0.7725-11.742.05-3.690.00
Waters Corp2.98bn657.02m20.84bn7.60k31.7910.6224.496.9911.0211.0250.0432.980.65562.314.45392,533.3014.4418.4118.0223.4659.2758.7122.0222.811.2813.770.4260.000.06674.22-0.68511.61-2.75--
Insulet Corp2.20bn402.20m21.18bn3.90k54.1815.9243.599.635.565.5629.7218.910.71611.496.08563,820.5013.106.0015.507.0370.3967.0518.299.223.6349.390.56030.0022.0722.92102.76104.84-4.75--
Steris PLC5.46bn610.12m23.37bn17.79k38.573.5421.484.286.166.2055.1167.180.51484.875.32306,938.505.775.046.365.5144.0143.7511.2010.691.3912.760.23637.516.2412.4910.648.4011.528.99
DexCom Inc4.15bn535.20m32.52bn10.30k63.5914.3542.767.841.301.3010.115.780.62692.893.89402,718.408.098.7912.4411.7560.7264.9712.9014.901.32--0.52460.0011.3422.276.4141.6314.79--
Agilent Technologies Inc6.63bn1.17bn34.48bn18.00k29.875.6223.895.204.064.0623.0921.610.5763.085.07370,279.3010.1310.9312.2513.0953.7753.3517.5917.931.6024.950.362921.83-4.734.753.953.7719.367.80
Data as of Jul 03 2025. Currency figures normalised to STERIS plc's reporting currency: US Dollar USD

Institutional shareholders

42.76%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202511.50m11.71%
BlackRock Fund Advisorsas of 31 Mar 20255.76m5.86%
WCM Investment Management LLCas of 31 Mar 20254.50m4.59%
SSgA Funds Management, Inc.as of 31 Mar 20254.09m4.16%
Massachusetts Financial Services Co.as of 31 Mar 20253.98m4.05%
Generation Investment Management LLPas of 31 Mar 20253.35m3.41%
Morgan Stanley Investment Management Ltd.as of 31 Mar 20252.60m2.65%
Geode Capital Management LLCas of 31 Mar 20252.43m2.48%
Select Equity Group LPas of 31 Mar 20252.22m2.26%
APG Asset Management NVas of 31 Mar 20251.57m1.60%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.